potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride

C27H47KO — CID 173311369

IUPACpotassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride
SMILESCC(C)CCC[C@@H](C)[C@H]1CCC2[C@H]3CC=C4CC(O)CC[C@]4(C)[C@@H]3CC[C@@]21C.[H-].[K+]
InChIInChI=1S/C27H46O.K.H/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5;;/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3;;/q;+1;-1/t19-,21?,22-,23-,24?,25-,26+,27-;;/m1../s1
InChIKeyLFKPCDNVUCPYGI-KGZBFUCYSA-N
MW426.77 g/mol
LogP4.51
Rot. Bonds5

About potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride

potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride (PubChem CID 173311369) has the molecular formula C27H47KO and a molecular weight of 426.77 g/mol. Its IUPAC name is potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride.

Molecular Properties

Compound Namepotassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride
PubChem CID173311369
Molecular FormulaC27H47KO
Molecular Weight426.77 g/mol
Exact Mass426.33
IUPAC Namepotassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride
SMILESCC(C)CCC[C@@H](C)[C@H]1CCC2[C@H]3CC=C4CC(O)CC[C@]4(C)[C@@H]3CC[C@@]21C.[H-].[K+]
InChIInChI=1S/C27H46O.K.H/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5;;/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3;;/q;+1;-1/t19-,21?,22-,23-,24?,25-,26+,27-;;/m1../s1
InChIKeyLFKPCDNVUCPYGI-KGZBFUCYSA-N
XLogP4.51
TPSA20.23 Ų
H-Bond Donors1
H-Bond Acceptors1
Rotatable Bonds5
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500426.77
LogP ≤ 54.51
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 101

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride?
The IUPAC name of potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride (CID 173311369) is potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride.
What is the SMILES notation for potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride?
The canonical SMILES for potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride is CC(C)CCC[C@@H](C)[C@H]1CCC2[C@H]3CC=C4CC(O)CC[C@]4(C)[C@@H]3CC[C@@]21C.[H-].[K+].
What is the InChIKey of potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride?
The InChIKey is LFKPCDNVUCPYGI-KGZBFUCYSA-N. The full InChI is InChI=1S/C27H46O.K.H/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5;;/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3;;/q;+1;-1/t19-,21?,22-,23-,24?,25-,26+,27-;;/m1../s1.
What are the key properties of potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride?
potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride has a molecular weight of 426.77 g/mol, XLogP of 4.51, 5 rotatable bonds, 1 hydrogen bond donors, and 1 hydrogen bond acceptors.
Where does this data come from?
All data for potassium;(8R,9R,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;hydride is sourced from PubChem (CID 173311369), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).